Who
Joseph Walter Vazzano
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Abeona Therapeutics; Director, Allarity Therapeutics; Chief Financial Officer, Avenue Therapeutics.
In numbers
- Trades disclosed
- 57
- Buys
- 6
- Sells
- 16
- Bought
- $77K
- Sold
- $1.7M
- Companies
- 3
- Companies where not an officer
- 1
- First trade
- 28 Jun 2018
- Last trade
- 29 Sep 2026
- Last filed
- 29 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $47K9,191 at $5.16 | filing |
| 29 Sep 2026filed 29 Sep 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $47K9,191 at $5.16 | filing |
| 21 Jul 2026filed 22 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,6511,478 at $6.53 | filing |
| 21 Jul 2026filed 22 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $9,6511,478 at $6.53 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K24,880 at $6.96 | filing |
| 9 Jul 2026filed 9 Jul 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K24,880 at $6.96 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K13,421 at $5.30 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $138K25,646 at $5.39 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K13,421 at $5.30 | filing |
| 9 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $138K25,646 at $5.39 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $56K10,271 at $5.43 | filing |
| 8 Jun 2026filed 9 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $56K10,271 at $5.43 | filing |
| 16 Mar 2026filed 16 Mar 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,737785 at $4.76 | filing |
| 16 Mar 2026filed 16 Mar 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $3,737785 at $4.76 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $100K18,666 at $5.33 | filing |
| 22 Jan 2026filed 22 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $99K18,666 at $5.33 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,595 at $0.00 | filing |
| 20 Jan 2026filed 20 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —133,595 at $0.00 | filing |
| 29 Sep 2025filed 1 Oct 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $49K9,035 at $5.39 | filing |
| 15 Aug 2025filed 15 Aug 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $110K15,000 at $7.36 | filing |
News
No headline names them, or the companies they trade most, lately.